Health and Science

Health and Human Services Secretary Alex Azar (on June 28th) pushes back against questioning from Finance Committee Ranking Member Ron Wyden over his agency's handling of over 2,000 migrant children placed in its custody as a result of the Trump administration's family-separation policy. Secretary Azar declines to provide specific numbers on how many parents know the whereabouts of their children, but says they can find the information at agency portals and with the help of case workers. more »

“My husband accidentally shot me,” Hill, 75, of The Dalles, Ore., groaned on the May 16, 2015, call. “In the stomach, and he can’t talk, please …” Less than four feet away, Hill’s husband, Darrell Hill, a former local police chief and two-term county sheriff, sat in his wheelchair with a discharged Glock handgun on the table in front of him, unaware that he’d nearly killed his wife of almost 57 years. The 76-year-old lawman had been diagnosed two years earlier with a form of rapidly progressive dementia, a disease that quickly stripped him of reasoning and memory. “He didn’t understand,” said Dee, who needed 30 pints of blood, three surgeries and seven weeks in the hospital to survive her injuries. more »

"Under the Federal Food, Drugs and Cosmetic Act (FD&C Act), a product intended to diagnose, mitigate, treat, or prevent disease, or to affect the structure or function of the body is classified as a drug. If such a product is not generally recognized by qualified experts as safe and effective when used as labeled, it is a “new drug” and requires an approved New Drug Application to be marketed legally in the United States. FDA issued Warning Letters, citing drug claims associated with topical skin care, hair care, and eyelash/eyebrow preparations, noted on both product labeling and Web sites. Some examples of the drug claims cited are acne treatment, cellulite reduction, stretch mark reduction, wrinkle removal, dandruff treatment, hair restoration, and eyelash growth." more »

Lawmakers from at least 30 states considered bills on pharmacy benefits managers this year. New laws have been enacted in more than a dozen states, with more awaiting governors’ signatures. Legislators were motivated to act on the issue “because it affects the ordinary consumer,” said Richard Cauchi, the health program director for the National Conference of State Legislatures... The gag clauses are inserted into contracts with pharmacies by pharmacy benefit management companies, and they prohibit druggists from telling patients or caregivers about lower prices or cheaper drug options, such as generic drugs.  more »